DL-3-n-butylphthalide, an anti-oxidant agent, prevents neurological deficits and cerebral injury following stroke per functional analysis, magnetic resonance imaging and histological assessment

Current Neurovascular Research

Volumn 9, Issue 3, 2012, Pages 167-175

  Zhang, Lihong ^a,b   Amy Yu, Wan Hua ^c   Wang, Yi Xiang J ^d   Wang, Chunmei ^a   Zhao, Feng ^d   Qi, Wei ^e   Chan, W M ^a   Huang, Yin ^f   Wai, Maria S M ^a   Dong, Jinghui ^e   Yew, D T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e Chinese University of Hong Kong   (Hong Kong)

^f Shijiazhuang Pharmaceutical Group Co   (China)

Author keywords

DL 3 n Butylphhalide; Infarct volume; Ischemic stroke; Magnetic resonance imaging; Middle cerebral artery occlusion; Neurological deficits; TTC staining

Indexed keywords

ANTIOXIDANT; DEXTRO LEVO 3 N BUTYLPHTHALIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

EID: 84865221402     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/156720212801618956     Document Type: Article

References (34)

1. Deng W, Feng Y. Effect of dl-3-n-butylphthalide on brain edema in rats subjected to focal cerebral ischemia. Chin Med Sci J 1997; 12(2):102-6. (Pubitemid 27264660)
2. Chong ZZ, Feng YP. dl-3-n-butylphthalide attenuates reperfusioninduced blood-brain barrier damage after focal cerebral ischemia in rats. Zhong Guo Yao Li Xue Bao 1999; 20(8):696-700.
3. Chang Q, Wang XL. Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats. Acta Pharmacol Sin 2003; 24(8):796-804. (Pubitemid 36988355)
4. Zhang Y, Wang L, Li J, Wang XL. 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia. J Pharmacol Exp Ther 2006; 317(3):973-9. (Pubitemid 43764099)
5. Yan C, Feng Y. Protective effects of d-, l-, and dl-3-nbutylphthalide on neuronal damage induced by hypoxia/hypoglycemia in cultured rat cortical neurons. Yao Xue Xue Bao 1998; 33(7):486-92. (Pubitemid 128465768)
6. Peng Y, Xing C, Lemere CA, et al. l-3-n-Butylphthalide ameliorates beta-amyloid-induced neuronal toxicity in cultured neuronal cells. Neurosci Lett 2008; 434(2):224-9.
7. Zhang T, Jia W, Sun X. 3-n-Butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats. Neurol Res 2010; 32(4):390-6.
8. Peng Y, Sun J, Hon S, et al. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease. J Neurosci 2010; 30(24):8180-9.
9. Feng X, Peng Y, Liu M, et al. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis. Neuropharmacology 2012; 62(2):1004-10.
10. Huang JZ, Chen YZ, Su M, et al. dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP (+)-induced cellular model of Parkinson's disease. Neurosci Lett 2010; 475(2):89-94.
11. Xiong N, Huang J, Chen C, et al. Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson's disease. Neurobiol Aging 2011; (Epub ahead of print)
12. Xu HL, Feng YP. Inhibitory effects of chiral 3-n-butylphthalide on inflammation following focal ischemic brain injury in rats. Acta Pharmacol Sin 2000; 21(5):433-8.
13. Wang X, Li Y, Zhao Q, et al. Design, synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as antiplatelet and antithrombotic agents. Org Biomol Chem 2011; 9(16):5670-81.
14. Cui LY, Li SW, Lü CZ, et al. The multicentric randomized study of dl-3-butylphthalide in the treatment of acute moderate ischemic stroke. Chin J Cerebrovasc Dis 2005; 2(3): 112-5.
15. Cui LY, Liu XQ, Zhu YC, et al. Effects of dl-3-Butylphthalide on treatment of acute ischemic stroke with moderate symptoms: a multi-center, randomized, double-blind, placebo-control trial. Chin J Neurol 2005; 38(4):251-4.
16. Zhang J, Jiang QQ. dl-3-butylphthalide in the Treatment of Acute Cerebral Infarction. Chin J Clin Neurosci 2006; 14(3), 281-4.
17. Wang DR, Liu M, Wu B. Dl-3-butylphthalide for Acute Ischemic Stroke: A Systematic Review. Chin J Evid-based Med 2010; 10(2): 189-95.
18. Pravenec M, Kurtz TW. Recent advances in genetics of the spontaneously hypertensive rat. Curr Hypertens Rep 2010; 12(1):5-9.
19. Nagasawa H, Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 1989; 20(8):1037-43. (Pubitemid 19204017)
20. Rogers DC, Campbell CA, Stretton JL, Mackay KB. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 1997; 28(10):2060-5; discussion 2066.
21. Wang YQ, Cui HR, Yang SZ, et al. VEGF enhance cortical newborn neurons and their neurite development in adult rat brain after cerebral ischemia. Neurochem Int 2009; 55(7):629-36.
22. Chao X, Zhou J, Chen T, et al. Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats. Brain Res 2010; 1363:206-11.
23. Li J, Li Y, Ogle M, et al. DL-3-n-butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway. Brain Res 2010; 1359:216-26.
24. Chrissobolis S, Miller AA, Drummond GR, et al. Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front Biosci 2011; 16:1733-45.
25. Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 2010; 12(2):135-42.
26. Sun B, Feng M, Tian X, et al. dl-3-n-Butylphthalide protects rat bone marrow stem cells against hydrogen peroxide-induced cell death through antioxidation and activation of PI3K-Akt pathway. Neurosci Lett 2012; 516(2):247-52.
27. Dong GX, Feng YP. Effects of NBP on ATPase and anti-oxidant enzymes activities and lipid peroxidation in transient focal cerebral ischemic rats. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002; 24(1):93-7.
28. Zhang L, Lü L, Chan WM, Huang Y, et al. Effects of DL-3-n-Butylphthalide on vascular dementia and angiogenesis. Neurochemical Research 2012; 37(5):911-9.
29. Ford RJ, Teschke SR, Reid EB, et al. AMP-activated protein kinase activator AICAR acutely lowers blood pressure and relaxes isolated resistance arteries of hypertensive rats. J Hypertens 2012; 30(4):725-33.
30. Zhang LY, Feng YP. Effect of dl-3-n-butylphthalide (NBP) on life span and neurological deficit in SHRsp rats. Yao Xue Xue Bao 1996; 31(1):18-23. (Pubitemid 126436151)
31. Amemiya M, Yashiro T, Kikuchi M, et al. Scanning and transmission electron microscopic observation of femoral head feeding vessels in stroke-prone spontaneously hypertensive rats. Med Mol Morphol 2011; 44(3):139-45.
32. Bailey EL, Wardlaw JM, Graham D, et al. Cerebral small vessel endothelial structural changes predate hypertension in stroke-prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5-to 21-week-old rats. Neuropathol Appl Neurobiol 2011; 37(7):711-26.
33. Ritz MF, Grond-Ginsbach C, Engelter S, et al. Gene expression suggests spontaneously hypertensive rats may have altered metabolism and reduced hypoxic tolerance. Curr Neurovasc Res 2012; 9(1):10-9.
34. Xiong J, Feng Y. Effect of dl-3-N-butylphthalide on the expression of hsp70 mRNA and c-fos in transient cerebral ischemic and reperfused rat brain. Yao Xue Xue Bao 1998; 33(6):401-6. (Pubitemid 128465779)